CANbridge Pharmaceuticals Inc. (1228.HK)
HKD 0.16
(0.65%)
HKD 0.16
(0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 102.87 Million | 78.97 Million | 31.16 Million | 12.03 Million | 1.46 Million |
| Cost of Revenue | 38.7 Million | 30.07 Million | 12.38 Million | 5.15 Million | 504 Thousand |
| Gross Profit | 64.16 Million | 48.89 Million | 18.77 Million | 6.87 Million | 965 Thousand |
| Operating Expenses | 64.16 Million | 498.4 Million | 673.51 Million | 237.97 Million | 137.81 Million |
| Selling, General and Administrative Expenses | 173.5 Million | 195.68 Million | 246.26 Million | 94.66 Million | 51.03 Million |
| Research and Development Expenses | 257.21 Million | 311.17 Million | 427.65 Million | 109.64 Million | 55.38 Million |
| Other Expenses | - | -31.42 Million | -466.6 Million | -591.29 Million | -78.94 Million |
| Cost and Expenses | 469.41 Million | 528.48 Million | 685.9 Million | 243.12 Million | 138.31 Million |
| Operating Income | -366.54 Million | -477.04 Million | -1.11 Billion | -821.5 Million | -216.3 Million |
| Interest Expense | 8.94 Million | 6.86 Million | 3.07 Million | 3.79 Million | 1.34 Million |
| Income Tax Expense | - | 21.74 Million | 15.46 Million | 17.63 Million | 3.42 Million |
| Earnings before Tax | -378.83 Million | -483.47 Million | -1.07 Billion | -846.04 Million | -217.67 Million |
| Net Income | -378.83 Million | -483.47 Million | -1.07 Billion | -846.04 Million | -217.67 Million |
| Earnings Per Share Basic | -0.89 | -1.14 | -11.43 | -1.99 | -0.51 |
| Earnings Per Share Diluted | -0.89 | -1.14 | -11.43 | -1.99 | -0.51 |
| Weighted Average Shares Outstanding | 424.37 Million | 424.21 Million | 94.24 Million | 424.19 Million | 424.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 424.37 Million | 424.21 Million | 94.24 Million | 424.19 Million | 424.19 Million |
| Gross Margin | 0.62 | 0.62 | 0.60 | 0.57 | 0.66 |
| EBIT Margin | -3.32 | -5.76 | -35.38 | -66.79 | -144.80 |
| Profit Margin | -3.68 | -6.12 | -34.56 | -70.32 | -148.18 |
| EBITDA | -341.42 Million | -454.63 Million | -1.05 Billion | -824.41 Million | -212.73 Million |
| Earnings Before Tax Margin | -3.56 | -6.04 | -35.88 | -68.28 | -147.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.39 Million | 22.39 Million | 29.91 Million | 102.87 Million | 29.91 Million | 21.52 Million |
| Cost of Revenue | 7.67 Million | 7.67 Million | 11.16 Million | 38.7 Million | 11.16 Million | 8.18 Million |
| Gross Profit | 14.71 Million | 14.71 Million | 18.74 Million | 64.16 Million | 18.74 Million | 13.33 Million |
| Operating Expenses | 124.34 Million | 124.34 Million | 100.6 Million | 429.27 Million | 102.32 Million | 120.18 Million |
| Selling, General and Administrative Expenses | 37.72 Million | 37.72 Million | 43.49 Million | - | 43.49 Million | 43.26 Million |
| Research and Development Expenses | 86.62 Million | 86.62 Million | 57.11 Million | - | 57.11 Million | 71.48 Million |
| Other Expenses | - | - | - | -15.99 Million | - | - |
| Cost and Expenses | 132.02 Million | 132.02 Million | 111.77 Million | 467.98 Million | 113.49 Million | 128.37 Million |
| Operating Income | -109.63 Million | -109.63 Million | -81.86 Million | -366.54 Million | -81.86 Million | -101.4 Million |
| Interest Expense | - | - | - | 8.94 Million | - | - |
| Income Tax Expense | - | - | - | -3.58 Million | - | - |
| Earnings before Tax | -123.63 Million | -123.63 Million | -80.33 Million | -378.83 Million | -80.33 Million | -109.08 Million |
| Net Income | -123.63 Million | -123.63 Million | -80.33 Million | -378.83 Million | -80.33 Million | -109.08 Million |
| Earnings Per Share Basic | -0.29 | -0.29 | -0.19 | - | -0.19 | -0.26 |
| Earnings Per Share Diluted | -0.29 | -0.29 | -0.19 | - | -0.19 | -0.26 |
| Weighted Average Shares Outstanding | 424.82 Million | 424.82 Million | 424.45 Million | 424.37 Million | 424.45 Million | 424.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 424.82 Million | 424.82 Million | 424.45 Million | 424.37 Million | 424.45 Million | 424.3 Million |
| Gross Margin | 0.66 | 0.66 | 0.63 | 0.62 | 0.63 | 0.62 |
| EBIT Margin | -4.75 | -4.75 | -2.63 | - | -2.63 | -4.59 |
| Profit Margin | -5.52 | -5.52 | -2.69 | -3.68 | -2.69 | -5.07 |
| EBITDA | -106.48 Million | -106.48 Million | -78.56 Million | - | -78.56 Million | -98.79 Million |
| Earnings Before Tax Margin | -4.89 | -4.89 | -2.74 | -3.56 | -2.74 | -4.71 |
THG
MGIDF
MQ
0JQZ
ERA
HLLGY